Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2006 1
2007 1
2008 1
2009 4
2010 1
2011 2
2012 4
2013 2
2014 3
2015 3
2016 1
2018 3
2019 3
2020 2
2021 3
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.
Scully M, Cataland SR, Peyvandi F, Coppo P, Knöbl P, Kremer Hovinga JA, Metjian A, de la Rubia J, Pavenski K, Callewaert F, Biswas D, De Winter H, Zeldin RK; HERCULES Investigators. Scully M, et al. N Engl J Med. 2019 Jan 24;380(4):335-346. doi: 10.1056/NEJMoa1806311. Epub 2019 Jan 9. N Engl J Med. 2019. PMID: 30625070 Free article. Clinical Trial.
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.
Broome CM, McDonald V, Miyakawa Y, Carpenedo M, Kuter DJ, Al-Samkari H, Bussel JB, Godar M, Ayguasanosa J, De Beuf K, Rodeghiero F, Michel M, Newland A; ADVANCE Investigator Study Group. Broome CM, et al. Lancet. 2023 Nov 4;402(10413):1648-1659. doi: 10.1016/S0140-6736(23)01460-5. Epub 2023 Sep 28. Lancet. 2023. PMID: 37778358 Clinical Trial.
Determination of Thrombogenicity Levels of Various Antiphospholipid Antibodies by a Modified Thrombin Generation Assay in Patients with Suspected Antiphospholipid Syndrome.
Bradáčová P, Slavík L, Skoumalová A, Úlehlová J, Kriegová E, Manukyan G, Friedecký D, Piskláková B, Ullrychová J, Procházková J, Hluší A. Bradáčová P, et al. Among authors: hlusi a. Int J Mol Sci. 2022 Aug 11;23(16):8973. doi: 10.3390/ijms23168973. Int J Mol Sci. 2022. PMID: 36012233 Free PMC article.
Determining Thrombogenicity: Using a Modified Thrombin Generation Assay to Detect the Level of Thrombotic Event Risk in Lupus Anticoagulant-Positive Patients.
Bradáčová P, Slavík L, Úlehlová J, Kriegová E, Jará E, Bultasová L, Friedecký D, Ullrychová J, Procházková J, Hluší A, Manukyan G, Štefaničková L. Bradáčová P, et al. Among authors: hlusi a. Biomedicines. 2023 Dec 16;11(12):3329. doi: 10.3390/biomedicines11123329. Biomedicines. 2023. PMID: 38137550 Free PMC article.
Thrombin Generation Testing in Patients with Myelofibrosis.
Palova M, Slavik L, Hlusi A, Szotkowski T, Ulehlova J, Divoka M, Navratilova J, Papajik T. Palova M, et al. Among authors: hlusi a. Clin Lab. 2018 Sep 1;64(9):1373-1383. doi: 10.7754/Clin.Lab.2018.180204. Clin Lab. 2018. PMID: 30274004
Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data).
Romanová G, Smejkal P, Ovesná P, Drbohlavová E, Dulíček P, Hajšmanová Z, Hluší A, Hrdličková R, Ullrychová J, Vonke I, Blatný J, Čermáková Z, Zápotocká E, Penka M. Romanová G, et al. Among authors: hlusi a. Ann Hematol. 2023 Nov;102(11):3261-3270. doi: 10.1007/s00277-023-05453-6. Epub 2023 Sep 23. Ann Hematol. 2023. PMID: 37740066 Free PMC article.
38 results